How diabetes affects blood vessel health and recovery after a stroke
Cerebrovascular O-GlcNAcylation Worsens Diabetes-associated Neurovascular Injury and Recovery Post-stroke
This study looks at how diabetes affects blood vessel health and recovery after a stroke, focusing on a specific change in proteins that might make things worse for diabetic patients; the goal is to find new ways to help these patients recover better after a stroke.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11192972 on NIH RePORTER |
What this research studies
This research investigates the impact of diabetes on the health of blood vessels and the recovery process following a stroke. It focuses on a specific modification called O-GlcNAcylation, which can alter the function of proteins involved in vascular health. By understanding how this modification worsens neurovascular injury in diabetic patients, the research aims to identify potential therapeutic targets to improve recovery outcomes. Patients with diabetes who experience strokes may benefit from insights gained through this research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who have experienced a stroke or are at high risk for stroke.
Not a fit: Patients without diabetes or those who have not experienced a stroke may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for diabetic patients who suffer from strokes, enhancing their recovery and reducing long-term complications.
How similar studies have performed: Previous research has shown that understanding vascular modifications in diabetes can lead to significant advancements in treatment strategies, indicating a promising avenue for this investigation.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Mccarthy, Cameron — University of South Carolina at Columbia
- Study coordinator: Mccarthy, Cameron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.